BP
BIIB icon

Banyan Partners’s Biogen BIIB Stock Holding History

Banyan Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$1.75M Sell
5,279
-509
-9% -$168K 0.15% 163
2014
Q2 		$1.82M Sell
5,788
-1,654
-22% -$498K 0.15% 164
2014
Q1 		$2.28M Sell
7,442
-659
-8% -$209K 0.2% 135
2013
Q4 		$2.27M Buy
+8,101
New +$2.1M 0.16% 141

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Banyan Partners's BIIB Position: Q3 2014 in Review

Banyan Partners reduced its Biogen (BIIB) stake by 8.8% in Q3 2014, selling an estimated $168K and leaving 5,279 shares worth $1.75M. The position accounts for 0.15% of the portfolio, ranked #163.

Banyan Partners first reported a position in BIIB in Q4 2013 and has held it in 4 quarters since. The position peaked at $2.28M in Q1 2014. 818 funds tracked by Wall St. Rank hold BIIB as of Q3 2014.

  • Banyan Partners held 5,279 shares of Biogen worth $1.75M as of Q3 2014.
  • Banyan Partners sold 509 Biogen shares in Q3 2014, an estimated $168K.
  • Biogen made up 0.15% of Banyan Partners's portfolio in Q3 2014, its #163 holding.
  • Banyan Partners first reported a position in Biogen in Q4 2013 and has held it in 4 quarters since.
  • Banyan Partners's Biogen position peaked at $2.28M in Q1 2014.
  • 818 funds tracked by Wall St. Rank held Biogen as of Q3 2014.

Based on Banyan Partners's 13F filing for Q3 2014, filed 14 Nov 2014.